PATENT CLAIM ANALYSIS

Application Number: 15861688
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["514", "235200"]

Abstract:
The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof. They are useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.

Claim (Index 4):
The compound of  claim 1 , wherein W is: or a stereoisomer thereof, and wherein W is substituted by 1, 2 or 3 R 14  groups.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.48718
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15257926', '14670425', '14670421', '14670422', '15300284']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7983014192393529
- 35 USC 102 Novelty (BERT): 0.5705341109648828
- Combined Prediction Score: 0.775524688411906
- Mean Citation Score: 402.676484
- Max Citation Score: 458.25174
- Similarity Product: 359.09342572683335

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test